drugset
drugset / Trial / NCT01587365

Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins

NCT01587365 ↗

Phase 1 Completed 66 enrolled Bristol-Myers Squibb
RandomizedSingle-groupDouble-blindTreatment

Summary

To obtain safety and tolerability information in healthy subjects is administered as a single dose

Timeline

Start
2012-05
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-962476 Unknown 0.01 mg/kg Subcutaneous
Subject BMS-962476 Unknown 0.03 mg/kg Subcutaneous
Subject BMS-962476 Unknown 0.1 mg/kg Subcutaneous
Subject BMS-962476 Unknown 0.3 mg/kg Subcutaneous
Subject BMS-962476 Unknown 1 mg/kg Subcutaneous

Indications

atherosclerosis